Table 3.
CLDN15 expression in the tissue microarray of non MPM primary tumors.
| Organ | Malignant tumor | CLDN15 | Specificity (%) |
|---|---|---|---|
| Cerebrum | Astrocytoma | 0/10 | 100 |
| Glioblastoma | 1/10 | 90 | |
| Thyroid gland | Papillary carcinoma | 0/10 | 100 |
| Follicular cell carcinoma | 1/10 | 90 | |
| Lung | Squamous cell carcinoma | 0/11 | 100 |
| Large cell carcinoma | 1/12 | 92 | |
| Small cell carcinoma | 0/12 | 100 | |
| Breast | Invasive ductal carcinoma | 0/19 | 100 |
| Esophagus | Adenocarcinoma | 0/10 | 100 |
| Squamous cell carcinoma | 0/10 | 100 | |
| Stomach | Adenocarcinoma | 0/20 | 100 |
| Liver | Hepatocellular carcinoma | 1/17 | 94 |
| Pancreas | Duct adenocarcinoma | 0/20 | 100 |
| Colon | Adenocarcinoma | 0/11 | 100 |
| Mucinous adenocarcinoma | 0/7 | 100 | |
| Kidney | Clear cell carcinoma | 6/20 | 70 |
| Bladder | Invasive urothelial carcinoma | 0/19 | 100 |
| Prostate | Adenocarcinoma | 1/20 | 95 |
| Testis | Seminoma | 0/10 | 100 |
| Embryonal carcinoma | 0/10 | 100 | |
| Ovary | High grade serous carcinoma | 1/9 | 89 |
| Mucinous adenocarcinoma | 0/10 | 100 | |
| Cervix | Squamous cell carcinoma | 0/20 | 100 |
| Uterus | Endometrioid adenocarcinoma | 0/20 | 100 |
| Total | 12/327 | 96.3 | |